AXSM R&D Expenses
Axsome Therapeutics Inc · R&D Expenses
AXSM R&D Expenses
Latest reported$187.86Mperiod ending
AXSM TTM R&D Expenses ($4.28M → $187.86M)
TTM R&D Expenses
High-resolution chart · PNG
AXSM r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 187,857,000 | |
| 191,171,000 | |
| 183,279,000 | |
| 189,494,000 | |
| 194,720,000 | |
| 195,032,000 | |
| 187,077,000 | |
| 162,874,000 | |
| 146,253,000 | |
| 116,981,000 | |
| 97,944,000 | |
| 81,834,083 | |
| 67,944,083 | |
| 63,155,083 | |
| 57,947,083 | |
| 57,035,453 | |
| 55,338,711 | |
| 54,050,037 | |
| 58,060,726 | |
| 61,664,002 | |
| 63,279,237 | |
| 59,318,868 | |
| 70,244,579 | |
| 72,065,121 | |
| 73,105,201 | |
| 73,565,386 | |
| 53,647,067 | |
| 41,593,028 | |
| 31,798,235 | |
| 26,345,625 | |
| 23,495,055 | |
| 20,837,733 | |
| 19,268,079 | |
| 18,724,908 | |
| 19,957,616 | |
| 21,270,477 | |
| 22,368,128 | |
| 22,658,827 | |
| 21,199,860 | |
| 17,601,004 | |
| 13,556,622 | |
| 9,886,956 | |
| 6,776,987 | |
| 5,916,599 | |
| 5,693,728 | |
| 4,880,408 | |
| 4,279,200 |